Biogenysis

Biogenysis is committed to advancing the field of drug discovery through artificial intelligence, using AI to improve drug discovery and expand our intellectual property portfolio. Biogenysis aims to identify early biomarkers of Alzheimer's disease and discover new therapeutic targets to slow its progression.